Jamile Shammo MD , FASCP, FACP

PubMed

• Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria.
  Jamile Shammo, Peter Hillmen, Peter Blandino, Vijay Abilash, David J Kuter
  International Journal of Molecular Sciences. 2025-10-15
• A prospective study of serum folate levels in patients with solid tumors treated with olaparib.
  Jamile Shammo, Laura Owczarzak, Nicole K Yun, Lois Winkelman, Sanjib Basu
  The Oncologist. 2025-10-01
• 13 citations
  Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
  Austin Kulasekararaj, Morag Griffin, Caroline Piatek, Jamile Shammo, Jun-Ichi Nishimura
  Blood. 2025-02-20

Abstracts/Posters

• Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
  Jamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Novel Patient Reported Outcome Instrument Assessing the Symptoms of Paroxysmal Nocturnal Hemoglobinuria
  Jamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database
  Jamile M. Shammo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Riding the Wave: Clinical Management of Myeloid Malignancies in an Era of Novel Therapies 
  60th American Society of Hematology Annual Meeting - 11/30/2018